Detalhe da pesquisa
1.
PD-1/PD-L1 inhibitor plus chemotherapy versus standard of care in the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma.
Eur Arch Otorhinolaryngol
; 280(1): 1-9, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35907001
2.
The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis.
Invest New Drugs
; 40(4): 810-817, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412172
3.
Combination therapy with immune checkpoint inhibitors in advanced renal cell carcinoma: A meta-analysis of randomized controlled trials.
Clin Immunol
; 232: 108876, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34740840
4.
Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma.
Lancet Oncol
; 24(1): e7, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603930
5.
Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma.
Lancet Oncol
; 24(6): e230, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269848
6.
Severe and fatal adverse events of immune checkpoint inhibitor combination therapy in patients with metastatic renal cell carcinoma: a systematic review and meta-analysis.
Front Immunol
; 14: 1196793, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37404816
7.
Efficacy of immune checkpoint inhibitor as maintenance therapy for advanced or metastatic cancers: A meta-analysis of randomized controlled trials.
Medicine (Baltimore)
; 101(38): e30830, 2022 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36197237
8.
Efficacy and safety of adjuvant therapy with PD1/PDL1 inhibitors in cancer.
Exp Ther Med
; 24(6): 749, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36561965
9.
Safety and efficacy of pembrolizumab plus lenvatinib versus pembrolizumab and lenvatinib monotherapies in cancers: A systematic review.
Int Immunopharmacol
; 91: 107281, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338862
10.
The efficacy and safety of combination therapy with immune checkpoint inhibitors in non-small cell lung cancer: A meta-analysis.
Int Immunopharmacol
; 96: 107594, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33798808
11.
Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab.
J Clin Oncol
; 42(13): 1596, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452320
12.
Tucatinib Plus Trastuzumab and Capecitabine for ERBB2 (HER2)-Positive Metastatic Breast Cancer With Brain Metastases.
JAMA Oncol
; 9(7): 1008-1009, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227708
13.
Low-Dose Immunotherapy Plus Triple Metronomic Chemotherapy for Head and Neck Cancer.
J Clin Oncol
; 41(9): 1790, 2023 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669141
14.
Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma.
J Clin Oncol
; 41(14): 2667-2668, 2023 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36940404
15.
Prenatal diagnosis of pulmonary atresia with ventricular septal defect.
J Med Ultrason (2001)
; 45(2): 341-344, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28752252
16.
Neratinib Plus Capecibine in Patients With HER2-Positive Metastatic Breast Cancer.
J Clin Oncol
; 39(3): 252-253, 2021 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332194
17.
Letter: sequential or combinated systemic treatment for unresectable hepatocellular carcinoma.
Aliment Pharmacol Ther
; 52(5): 915-916, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852832
18.
Letter: female patients with hepatocellular carcinoma may have better prognosis than male patients.
Aliment Pharmacol Ther
; 52(11-12): 1769-1770, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205877